Acquisition of Epithelial-mesenchymal Transition and Cancer Stem Cell Phenotypes is Associated with Activation of the PI3K/Akt/mTOR Pathway in Prostate Cancer Radioresistance

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2013 Oct 26

PMID 24157869

Citations 207

Authors

L Chang

P H Graham

J Hao

J Ni

J Bucci

P J Cozzi

J H Kearsley

Y Li

Affiliations

Soon will be listed here.

Abstract

Radioresistance is a major challenge in prostate cancer (CaP) radiotherapy (RT). In this study, we investigated the role and association of epithelial-mesenchymal transition (EMT), cancer stem cells (CSCs) and the PI3K/Akt/mTOR signaling pathway in CaP radioresistance. We developed three novel CaP radioresistant (RR) cell lines (PC-3RR, DU145RR and LNCaPRR) by radiation treatment and confirmed their radioresistance using a clonogenic survival assay. Compared with untreated CaP-control cells, the CaP-RR cells had increased colony formation, invasion ability and spheroid formation capability (P<0.05). In addition, enhanced EMT/CSC phenotypes and activation of the checkpoint proteins (Chk1 and Chk2) and the PI3K/Akt/mTOR signaling pathway proteins were also found in CaP-RR cells using immunofluorescence, western blotting and quantitative real-time PCR (qRT-PCR). Furthermore, combination of a dual PI3K/mTOR inhibitor (BEZ235) with RT effectively increased radiosensitivity and induced more apoptosis in CaP-RR cells, concomitantly correlated with the reduced expression of EMT/CSC markers and the PI3K/Akt/mTOR signaling pathway proteins compared with RT alone. Our findings indicate that CaP radioresistance is associated with EMT and enhanced CSC phenotypes via activation of the PI3K/Akt/mTOR signaling pathway, and that the combination of BEZ235 with RT is a promising modality to overcome radioresistance in the treatment of CaP. This combination approach warrants future in vivo animal study and clinical trials.

Citing Articles

(Porifera) Is Highly Resistant to Radiation Exposure and Possibly Cancer.

Fortunato A, Taylor J, Scirone J, Seyedi S, Aktipis A, Maley C Biology (Basel). 2025; 14(2).

PMID: 40001939 PMC: 11851485. DOI: 10.3390/biology14020171.

Targeting Fibroblast-Derived Interleukin 6: A Strategy to Overcome Epithelial-Mesenchymal Transition and Radioresistance in Head and Neck Cancer.

Li X, Escoffier H, Sauter T, Tavassoli M Cancers (Basel). 2025; 17(2).

PMID: 39858048 PMC: 11763410. DOI: 10.3390/cancers17020267.

Anti-Inflammatory 8-Shogaol Mediates Apoptosis by Inducing Oxidative Stress and Sensitizes Radioresistance in Gastric Cancer.

Kim T, Lee H Int J Mol Sci. 2025; 26(1.

PMID: 39796030 PMC: 11719885. DOI: 10.3390/ijms26010173.

Myriad factors and pathways influencing tumor radiotherapy resistance.

Mi L, Zhang H Open Life Sci. 2024; 19(1):20220992.

PMID: 39655194 PMC: 11627069. DOI: 10.1515/biol-2022-0992.

Three-dimensional imaging of upper tract urothelial carcinoma improves diagnostic yield and accuracy.

Fukumoto K, Kanatani S, Jaremko G, West Z, Li Y, Takamatsu K JCI Insight. 2024; 9(14).

PMID: 39133649 PMC: 11383588. DOI: 10.1172/jci.insight.175751.

References

Sarkar F, Li Y, Wang Z, Kong D . The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer. Cancer Metastasis Rev. 2010; 29(3):383-94. PMC: 2974632. DOI: 10.1007/s10555-010-9233-4. View

Jeter C, Liu B, Liu X, Chen X, Liu C, Calhoun-Davis T . NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene. 2011; 30(36):3833-45. PMC: 3140601. DOI: 10.1038/onc.2011.114. View

Tiwari N, Gheldof A, Tatari M, Christofori G . EMT as the ultimate survival mechanism of cancer cells. Semin Cancer Biol. 2012; 22(3):194-207. DOI: 10.1016/j.semcancer.2012.02.013. View

Eade T, Hanlon A, Horwitz E, Buyyounouski M, Hanks G, Pollack A . What dose of external-beam radiation is high enough for prostate cancer?. Int J Radiat Oncol Biol Phys. 2007; 68(3):682-9. PMC: 2770596. DOI: 10.1016/j.ijrobp.2007.01.008. View

Kong D, Li Y, Wang Z, Sarkar F . Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?. Cancers (Basel). 2011; 3(1):716-29. PMC: 3106306. DOI: 10.3390/cancers30100716. View

Wang X, Ma Z, Xiao Z, Liu H, Dou Z, Feng X . Chk1 knockdown confers radiosensitization in prostate cancer stem cells. Oncol Rep. 2012; 28(6):2247-54. DOI: 10.3892/or.2012.2068. View

Chao H, Wang L, Hao J, Ni J, Chang L, Graham P . Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathway in vitro. Cancer Lett. 2012; 329(1):17-26. DOI: 10.1016/j.canlet.2012.08.035. View

Chang L, Graham P, Hao J, Bucci J, Cozzi P, Kearsley J . Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy. Cancer Metastasis Rev. 2014; 33(2-3):469-96. DOI: 10.1007/s10555-014-9493-5. View

Della Donna L, Lagadec C, Pajonk F . Radioresistance of prostate cancer cells with low proteasome activity. Prostate. 2011; 72(8):868-74. PMC: 3396561. DOI: 10.1002/pros.21489. View

10.

Jemal A, Siegel R, Xu J, Ward E . Cancer statistics, 2010. CA Cancer J Clin. 2010; 60(5):277-300. DOI: 10.3322/caac.20073. View

11.

Ni J, Cozzi P, Duan W, Shigdar S, Graham P, John K . Role of the EpCAM (CD326) in prostate cancer metastasis and progression. Cancer Metastasis Rev. 2012; 31(3-4):779-91. DOI: 10.1007/s10555-012-9389-1. View

12.

Nishida S, Hirohashi Y, Torigoe T, Kitamura H, Takahashi A, Masumori N . Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay. J Urol. 2012; 188(1):294-9. DOI: 10.1016/j.juro.2012.02.2555. View

13.

Yu C, Shiozawa Y, Taichman R, McCauley L, Pienta K, Keller E . Prostate cancer and parasitism of the bone hematopoietic stem cell niche. Crit Rev Eukaryot Gene Expr. 2012; 22(2):131-48. PMC: 3615416. DOI: 10.1615/critreveukargeneexpr.v22.i2.50. View

14.

Khan M, Walsh P, Miller M, Bales W, Epstein J, Mangold L . Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy. Cancer. 2003; 98(12):2583-91. DOI: 10.1002/cncr.11852. View

15.

Xiao W, Graham P, Power C, Hao J, Kearsley J, Li Y . CD44 is a biomarker associated with human prostate cancer radiation sensitivity. Clin Exp Metastasis. 2011; 29(1):1-9. DOI: 10.1007/s10585-011-9423-7. View

16.

Hay E . The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn. 2005; 233(3):706-20. DOI: 10.1002/dvdy.20345. View

17.

Bao S, Wu Q, McLendon R, Hao Y, Shi Q, Hjelmeland A . Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444(7120):756-60. DOI: 10.1038/nature05236. View

18.

Jung P, Sato T, Merlos-Suarez A, Barriga F, Iglesias M, Rossell D . Isolation and in vitro expansion of human colonic stem cells. Nat Med. 2011; 17(10):1225-7. DOI: 10.1038/nm.2470. View

19.

Wang L, Chen H, Liu F, Madigan M, Power C, Hao J . Monoclonal antibody targeting MUC1 and increasing sensitivity to docetaxel as a novel strategy in treating human epithelial ovarian cancer. Cancer Lett. 2010; 300(2):122-33. DOI: 10.1016/j.canlet.2010.09.013. View

20.

Mani S, Guo W, Liao M, Eaton E, Ayyanan A, Zhou A . The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133(4):704-15. PMC: 2728032. DOI: 10.1016/j.cell.2008.03.027. View